Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Inventory: 2015-2025

Historic Inventory for Aytu Biopharma (AYTU) over the last 11 years, with Sep 2025 value amounting to $10.1 million.

  • Aytu Biopharma's Inventory fell 13.96% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year decrease of 13.96%. This contributed to the annual value of $11.4 million for FY2025, which is 5.82% down from last year.
  • As of Q3 2025, Aytu Biopharma's Inventory stood at $10.1 million, which was down 11.67% from $11.4 million recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Inventory registered a high of $16.6 million during Q1 2021, and its lowest value of $10.1 million during Q3 2025.
  • Moreover, its 3-year median value for Inventory was $12.0 million (2023), whereas its average is $12.0 million.
  • In the last 5 years, Aytu Biopharma's Inventory skyrocketed by 330.02% in 2021 and then plummeted by 33.60% in 2022.
  • Aytu Biopharma's Inventory (Quarterly) stood at $16.6 million in 2021, then dropped by 21.79% to $12.9 million in 2022, then climbed by 0.39% to $13.0 million in 2023, then decreased by 14.74% to $11.1 million in 2024, then decreased by 13.96% to $10.1 million in 2025.
  • Its Inventory was $10.1 million in Q3 2025, compared to $11.4 million in Q2 2025 and $11.1 million in Q1 2025.